569 related articles for article (PubMed ID: 19040460)
1. Selecting empiric antibiotic therapy in an era of multi-drug resistance--is the cupboard really bare? Introduction.
Collatz E
Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():1. PubMed ID: 19040460
[No Abstract] [Full Text] [Related]
2. Predicting antibiotic resistance.
Martínez JL; Baquero F; Andersson DI
Nat Rev Microbiol; 2007 Dec; 5(12):958-65. PubMed ID: 18007678
[TBL] [Abstract][Full Text] [Related]
3. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents.
Payne D; Tomasz A
Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496
[No Abstract] [Full Text] [Related]
4. Whither antibacterial drug discovery?
Projan SJ
Drug Discov Today; 2008 Apr; 13(7-8):279-80. PubMed ID: 18405838
[No Abstract] [Full Text] [Related]
5. Challenges in the management of serious infections.
Rehm SJ; Bartlett JG
Clin Infect Dis; 2006 Jan; 42 Suppl 2():S63-4. PubMed ID: 16355318
[No Abstract] [Full Text] [Related]
6. Integrons: adding another threat to the use of antibiotic therapy.
Norrby SR
Clin Infect Dis; 2005 Jul; 41(1):10-1. PubMed ID: 15937756
[No Abstract] [Full Text] [Related]
7. Antibiotics and antibiotic resistance genes in natural environments.
Martínez JL
Science; 2008 Jul; 321(5887):365-7. PubMed ID: 18635792
[TBL] [Abstract][Full Text] [Related]
8. What is inadequate antibacterial therapy?
Moellering RC
Clin Infect Dis; 2009 Oct; 49(7):1006-8. PubMed ID: 19719418
[No Abstract] [Full Text] [Related]
9. Therapy of patients with resistant bacterial infections.
Rahal JJ
Bull N Y Acad Med; 1987 Apr; 63(3):318-29. PubMed ID: 3300830
[No Abstract] [Full Text] [Related]
10. Colistin in the treatment of life-threatening infections.
Pavleas J; Skiada A; Daikos GL; Rigas K; Mega A; Archondoulis N; Vernikos P; Salatas K; Thomopoulos G
Int J Antimicrob Agents; 2006 Oct; 28(4):374-6. PubMed ID: 16963234
[No Abstract] [Full Text] [Related]
11. Late stage antibacterial drugs in the clinical pipeline.
Projan SJ; Bradford PA
Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
[TBL] [Abstract][Full Text] [Related]
12. [Which partner for the betalactam agent in empiric combined therapy? I Fluoroquinolone].
Bedos JP
Ann Fr Anesth Reanim; 2004 Jun; 23(6):636-8. PubMed ID: 15234734
[No Abstract] [Full Text] [Related]
13. [Ecological impact of antibiotic treatment of dental infections].
Granizo JJ; Giménez MJ; Bascones A; Aguilar L
Rev Esp Quimioter; 2006 Mar; 19(1):14-20. PubMed ID: 16688287
[No Abstract] [Full Text] [Related]
14. Can better prescribing turn the tide of resistance?
Livermore D
Nat Rev Microbiol; 2004 Jan; 2(1):73-8. PubMed ID: 15035011
[TBL] [Abstract][Full Text] [Related]
15. Acute otitis media: antimicrobial therapy in an era of resistant bacteria and sceptical meta-analysticians.
Teele DW
N Z Med J; 2000 Jul; 113(1113):284-6. PubMed ID: 10935569
[No Abstract] [Full Text] [Related]
16. Battle of the bugs.
Sleator RD; Hill C
Science; 2008 Sep; 321(5894):1294-5. PubMed ID: 18772416
[No Abstract] [Full Text] [Related]
17. Methodology of prevention of antibiotic resistance.
Shetty A
J Assoc Physicians India; 2010 Dec; 58 Suppl():47-8. PubMed ID: 21568010
[No Abstract] [Full Text] [Related]
18. Introduction into antibiotic combination treatment.
Ellorhaoui M
Ther Hung; 1978; 26(1):3-11. PubMed ID: 663873
[No Abstract] [Full Text] [Related]
19. Does microbial resistance matter?
Vincent JL
Lancet Infect Dis; 2011 Jan; 11(1):3-4. PubMed ID: 21126916
[No Abstract] [Full Text] [Related]
20. Multi-targeting by monotherapeutic antibacterials.
Silver LL
Nat Rev Drug Discov; 2007 Jan; 6(1):41-55. PubMed ID: 17159922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
